Mining and translating the extensive chemical signaling between humans and their microbiome

Our innovative technology merges large-scale screening of proprietary human-derived metabolite libraries, with modern computational metabolomics, machine-learning approaches, and synthetic chemistry. We believe our approach will yield a profound and functional understanding of the interplay between human and human microbiome systems, and pave the way for a new generation of deeply impactful, safer, and more effective therapeutic products across a range of debilitating diseases.


© 2019 Galileo Biosystems, Inc. | Website Design and Development by MJR Designer